Proteasome Inhibitors Diminish c-Met Expression and Induce Cell Death in Non-Small Cell Lung Cancer Cells

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer and accounts for 85% of all lung carcinomas. The hepatocyte growth factor receptor (c-Met) has been considered as a potential therapeutic target for NSCLC. Proteasome inhibition induces cell apoptosis and has been used as a no...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yanhui, Dong, Su, Tamaskar, Arya, Wang, Heather, Zhao, Jing, Ma, Haichun, Zhao, Yutong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cognizant Communication Corporation 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751221/
https://www.ncbi.nlm.nih.gov/pubmed/32580819
http://dx.doi.org/10.3727/096504020X15929939001042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751221/
https://www.ncbi.nlm.nih.gov/pubmed/32580819
http://dx.doi.org/10.3727/096504020X15929939001042

Ejemplares similares